Underestimation of Harms in Phase I Trials

J Law Med Ethics. 2019 Jun;47(2):334-335. doi: 10.1177/1073110519857290.

Authors

Karolina Strzebonska¹, Marcin Waligora¹

Affiliation

¹ Karolina Strzebonska, M.Eng., is a Ph.D. candidate at the Faculty of Health Sciences at the Jagiellonian University Medical College and the member of REMEDY, Research Ethics in Medicine Study Group. Marcin Waligora, Ph.D., is a Professor at the Department of Philosophy and Bioethics, Jagiellonian University Medical College in Krakow, Poland.

PMID: 31298104
DOI: 10.1177/1073110519857290

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Clinical Trials, Phase I as Topic*
Drug-Related Side Effects and Adverse Reactions
Harm Reduction*
Healthy Volunteers*
Humans